GSA Capital Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-52,119
| Closed | -$820K | – | 2126 |
|
|
2024
Q1 | $820K | Sell |
52,119
-80,011
| -61% | -$1.26M | 0.07% | 577 |
|
|
2023
Q4 | $2.13M | Sell |
132,130
-30,569
| -19% | -$493K | 0.18% | 101 |
|
|
2023
Q3 | $2.07M | Buy |
162,699
+42,604
| +35% | +$542K | 0.18% | 102 |
|
|
2023
Q2 | $1.69M | Buy |
120,095
+17,864
| +17% | +$252K | 0.17% | 101 |
|
|
2023
Q1 | $1.58M | Buy |
102,231
+33,942
| +50% | +$524K | 0.16% | 129 |
|
|
2022
Q4 | $1.12M | Buy |
68,289
+54,042
| +379% | +$886K | 0.14% | 169 |
|
|
2022
Q3 | $264K | Sell |
14,247
-10,676
| -43% | -$198K | 0.04% | 1018 |
|
|
2022
Q2 | $328K | Buy |
24,923
+6,210
| +33% | +$81.7K | 0.05% | 769 |
|
|
2022
Q1 | $173K | Buy |
18,713
+3,325
| +22% | +$30.7K | 0.02% | 1207 |
|
|
2021
Q4 | $150K | Sell |
15,388
-45,162
| -75% | -$440K | 0.02% | 1271 |
|
|
2021
Q3 | $2.06M | Buy |
+60,550
| New | +$2.06M | 0.21% | 55 |
|
|
2021
Q1 | – | Sell |
-4,890
| Closed | -$279K | – | 1576 |
|
|
2020
Q4 | $279K | Buy |
+4,890
| New | +$279K | 0.05% | 780 |
|
|
2020
Q2 | – | Sell |
-9,548
| Closed | -$393K | – | 1213 |
|
|
2020
Q1 | $393K | Buy |
+9,548
| New | +$393K | 0.1% | 294 |
|